The FDA Law Blog

FEBRUARY 28, 2023

Houck — The Drug Enforcement Administration’s (“DEA’s”) February 13th determination that THC acetate ester (“THCO”) is a schedule I controlled substance under the federal Controlled Substances Act (“CSA”) has received a good amount of attention in the cannabis press. By Larry K. Terrence L. Boos, Ph.D.,

Controlled Substances 58

Controlled Substances Compounding 58

pharmaphorum

SEPTEMBER 5, 2022

One, someone who should not be able to get their hands on these controlled substances can. Criminals gaining access to controlled substances by simply picking them up at pharmacies is incredibly problematic, especially considering the massive and ongoing opioid crisis.

Compounding 136

Compounding Controlled Substances 136

The FDA Law Blog

JANUARY 18, 2024

Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. 29, 2023). HHS forwards FDA’s analysis and recommendation to DEA.

FDA 69

FDA Controlled Substances Chemotherapy Compounding 69

The FDA Law Blog

JANUARY 8, 2023

As discussed in more detail below, the Act facilitates research of cannabis and its derivatives including cannabidiol (“CBD”), extracts, preparations and compounds, and the development of approved medications. Federal Research. 21 U.S.C. § 812(b)(1)(B). Such other conduct which may threaten the public health and safety. 21 U.S.C. §

Controlled Substances 64

Controlled Substances Inventory Control Compounding FDA 64